HEADER VIRAL PROTEIN/IMMUNE SYSTEM 20-NOV-06 2NY0 TITLE HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, TITLE 2 S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENVELOPE GLYCOPROTEIN GP120; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CORE; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: T-CELL SURFACE GLYCOPROTEIN CD4; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: D1D2, N-TERMINAL TWO DOMAIN FRAGMENT; COMPND 11 SYNONYM: T-CELL SURFACE ANTIGEN T4/LEU-3; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: ANTIBODY 17B, LIGHT CHAIN; COMPND 15 CHAIN: C; COMPND 16 FRAGMENT: ANTIGEN-BINDING FRAGMENT, FAB; COMPND 17 ENGINEERED: YES; COMPND 18 MOL_ID: 4; COMPND 19 MOLECULE: ANTIBODY 17B, HEAVY CHAIN; COMPND 20 CHAIN: D; COMPND 21 FRAGMENT: ANTIGEN-BINDING FRAGMENT, FAB; COMPND 22 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1; SOURCE 3 ORGANISM_TAXID: 11676; SOURCE 4 STRAIN: HXBC2; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: EMBRYONIC CELL LINE 293; SOURCE 9 EXPRESSION_SYSTEM_ORGAN: KIDNEY; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: CMVR; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 GENE: CD4; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 24 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 26 EXPRESSION_SYSTEM_CELL_LINE: EPSTEIN-BARR VIRUS IMMORTALIZED B-CELL SOURCE 27 CLONE FUSED WITH A MURINE B-CELL FUSION PARTNER; SOURCE 28 MOL_ID: 4; SOURCE 29 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 30 ORGANISM_COMMON: HUMAN; SOURCE 31 ORGANISM_TAXID: 9606; SOURCE 32 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 33 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 34 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 35 EXPRESSION_SYSTEM_CELL_LINE: EPSTEIN-BARR VIRUS IMMORTALIZED B-CELL SOURCE 36 CLONE FUSED WITH A MURINE B-CELL FUSION PARTNER KEYWDS HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.ZHOU,L.XU,B.DEY,A.J.HESSELL,D.VAN RYK,S.H.XIANG,X.YANG,M.Y.ZHANG, AUTHOR 2 M.B.ZWICK,J.ARTHOS,D.R.BURTON,D.S.DIMITROV,J.SODROSKI,R.WYATT, AUTHOR 3 G.J.NABEL,P.D.KWONG REVDAT 7 30-AUG-23 2NY0 1 HETSYN REVDAT 6 29-JUL-20 2NY0 1 COMPND SEQADV HETNAM LINK REVDAT 5 18-OCT-17 2NY0 1 REMARK REVDAT 4 13-JUL-11 2NY0 1 VERSN REVDAT 3 24-FEB-09 2NY0 1 VERSN REVDAT 2 27-FEB-07 2NY0 1 JRNL REVDAT 1 06-FEB-07 2NY0 0 JRNL AUTH T.ZHOU,L.XU,B.DEY,A.J.HESSELL,D.VAN RYK,S.H.XIANG,X.YANG, JRNL AUTH 2 M.Y.ZHANG,M.B.ZWICK,J.ARTHOS,D.R.BURTON,D.S.DIMITROV, JRNL AUTH 3 J.SODROSKI,R.WYATT,G.J.NABEL,P.D.KWONG JRNL TITL STRUCTURAL DEFINITION OF A CONSERVED NEUTRALIZATION EPITOPE JRNL TITL 2 ON HIV-1 GP120. JRNL REF NATURE V. 445 732 2007 JRNL REFN ISSN 0028-0836 JRNL PMID 17301785 JRNL DOI 10.1038/NATURE05580 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.34 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 80.2 REMARK 3 NUMBER OF REFLECTIONS : 48417 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2591 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2235 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 50.46 REMARK 3 BIN R VALUE (WORKING SET) : 0.2410 REMARK 3 BIN FREE R VALUE SET COUNT : 111 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7105 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 176 REMARK 3 SOLVENT ATOMS : 381 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.44000 REMARK 3 B22 (A**2) : 1.45000 REMARK 3 B33 (A**2) : 2.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.320 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.232 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.181 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.698 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7451 ; 0.005 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10123 ; 0.893 ; 1.976 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 917 ; 4.955 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 305 ;33.651 ;25.016 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1236 ;14.792 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 31 ;15.552 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1166 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5475 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2983 ; 0.216 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4998 ; 0.321 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 730 ; 0.206 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 65 ; 0.203 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 27 ; 0.237 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4676 ; 0.525 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7433 ; 0.903 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3096 ; 0.458 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2690 ; 0.756 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 8 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 83 A 254 REMARK 3 RESIDUE RANGE : A 475 A 491 REMARK 3 ORIGIN FOR THE GROUP (A): 23.6390 -26.7520 79.1130 REMARK 3 T TENSOR REMARK 3 T11: 0.2761 T22: -0.2003 REMARK 3 T33: -0.1656 T12: -0.0697 REMARK 3 T13: -0.0328 T23: -0.0814 REMARK 3 L TENSOR REMARK 3 L11: 2.9402 L22: 9.9876 REMARK 3 L33: 2.3660 L12: -3.0868 REMARK 3 L13: 0.6516 L23: -1.1694 REMARK 3 S TENSOR REMARK 3 S11: 0.1196 S12: 0.1036 S13: -0.6390 REMARK 3 S21: -0.2400 S22: -0.1168 S23: 0.5001 REMARK 3 S31: 0.4571 S32: 0.0381 S33: -0.0028 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 255 A 474 REMARK 3 ORIGIN FOR THE GROUP (A): 36.9370 -15.6720 90.7220 REMARK 3 T TENSOR REMARK 3 T11: 0.1535 T22: -0.3428 REMARK 3 T33: -0.3086 T12: -0.0097 REMARK 3 T13: -0.0080 T23: 0.0361 REMARK 3 L TENSOR REMARK 3 L11: 2.0072 L22: 3.3833 REMARK 3 L33: 2.4880 L12: -1.0091 REMARK 3 L13: 0.1442 L23: -0.1409 REMARK 3 S TENSOR REMARK 3 S11: -0.0489 S12: -0.1105 S13: -0.1160 REMARK 3 S21: 0.2654 S22: 0.0181 S23: -0.2961 REMARK 3 S31: 0.0651 S32: 0.2793 S33: 0.0308 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1001 B 1097 REMARK 3 ORIGIN FOR THE GROUP (A): 44.3450 -8.1540 67.4310 REMARK 3 T TENSOR REMARK 3 T11: 0.4007 T22: -0.2161 REMARK 3 T33: -0.2349 T12: 0.0291 REMARK 3 T13: 0.1246 T23: 0.0338 REMARK 3 L TENSOR REMARK 3 L11: 8.2612 L22: 1.7785 REMARK 3 L33: 3.2826 L12: 1.4134 REMARK 3 L13: -3.0463 L23: -1.5162 REMARK 3 S TENSOR REMARK 3 S11: -0.0636 S12: 0.5948 S13: -0.3261 REMARK 3 S21: -0.4183 S22: 0.0033 S23: -0.4545 REMARK 3 S31: 0.1016 S32: -0.0159 S33: 0.0603 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1098 B 1181 REMARK 3 ORIGIN FOR THE GROUP (A): 61.6040 16.6720 55.7640 REMARK 3 T TENSOR REMARK 3 T11: 0.2448 T22: -0.1247 REMARK 3 T33: -0.3333 T12: 0.0184 REMARK 3 T13: 0.0429 T23: 0.0195 REMARK 3 L TENSOR REMARK 3 L11: 4.1485 L22: 5.9791 REMARK 3 L33: 4.8697 L12: 3.8349 REMARK 3 L13: -0.1575 L23: -1.1582 REMARK 3 S TENSOR REMARK 3 S11: -0.2059 S12: -0.4280 S13: -0.3479 REMARK 3 S21: 0.1163 S22: -0.0155 S23: -0.0075 REMARK 3 S31: 0.4275 S32: -0.2447 S33: 0.2215 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 2001 C 2110 REMARK 3 ORIGIN FOR THE GROUP (A): 3.0890 22.2750 90.1890 REMARK 3 T TENSOR REMARK 3 T11: 0.1149 T22: -0.2556 REMARK 3 T33: -0.4233 T12: 0.0016 REMARK 3 T13: 0.0034 T23: -0.0069 REMARK 3 L TENSOR REMARK 3 L11: 1.7708 L22: 4.9412 REMARK 3 L33: 2.1074 L12: -1.9026 REMARK 3 L13: -0.5358 L23: 0.9062 REMARK 3 S TENSOR REMARK 3 S11: -0.0557 S12: -0.1832 S13: -0.0935 REMARK 3 S21: 0.4078 S22: -0.0512 S23: 0.2468 REMARK 3 S31: 0.1211 S32: -0.1320 S33: 0.1069 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 2111 C 2214 REMARK 3 ORIGIN FOR THE GROUP (A): -12.2590 49.6470 72.9470 REMARK 3 T TENSOR REMARK 3 T11: 0.2816 T22: -0.0152 REMARK 3 T33: -0.2332 T12: 0.2099 REMARK 3 T13: -0.0788 T23: -0.0810 REMARK 3 L TENSOR REMARK 3 L11: 2.0057 L22: 3.1032 REMARK 3 L33: 10.3385 L12: -0.8847 REMARK 3 L13: -0.4813 L23: -0.4272 REMARK 3 S TENSOR REMARK 3 S11: 0.1865 S12: 0.4073 S13: 0.3273 REMARK 3 S21: -0.5172 S22: -0.2146 S23: 0.3111 REMARK 3 S31: -0.9044 S32: -1.3461 S33: 0.0281 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 3001 D 3127 REMARK 3 ORIGIN FOR THE GROUP (A): 15.3800 18.2780 72.8990 REMARK 3 T TENSOR REMARK 3 T11: 0.0664 T22: -0.3334 REMARK 3 T33: -0.4028 T12: 0.0270 REMARK 3 T13: 0.0075 T23: -0.0082 REMARK 3 L TENSOR REMARK 3 L11: 1.2843 L22: 3.2935 REMARK 3 L33: 3.4416 L12: -1.3031 REMARK 3 L13: 1.1562 L23: -1.7156 REMARK 3 S TENSOR REMARK 3 S11: 0.0596 S12: 0.0456 S13: 0.0504 REMARK 3 S21: -0.1407 S22: -0.1400 S23: -0.2334 REMARK 3 S31: 0.1815 S32: 0.1320 S33: 0.0804 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D 3128 D 3229 REMARK 3 ORIGIN FOR THE GROUP (A): 3.9580 51.5070 68.8470 REMARK 3 T TENSOR REMARK 3 T11: 0.3549 T22: -0.2808 REMARK 3 T33: -0.2036 T12: -0.0090 REMARK 3 T13: 0.0472 T23: -0.0443 REMARK 3 L TENSOR REMARK 3 L11: 3.0693 L22: 5.3113 REMARK 3 L33: 7.4561 L12: 0.4259 REMARK 3 L13: -0.0967 L23: 3.7297 REMARK 3 S TENSOR REMARK 3 S11: 0.1967 S12: -0.0348 S13: 0.7185 REMARK 3 S21: -0.4615 S22: 0.1758 S23: -0.2150 REMARK 3 S31: -1.3024 S32: 0.3623 S33: -0.3725 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: AUTHORS STATE THAT BECAUSE CRYSTALS REMARK 3 WERE SMALL AND SUBJECT TO HIGH RADIATION DOSAGES DURING DATA REMARK 3 COLLECTION, DIFFERENCE FOURIERS COMPARING THE INITIAL AND FINAL REMARK 3 SWATCHES OF DATA WERE INSPECTED TO IDENTIFY RADIATION-INDUCED REMARK 3 DISULFIDE BREAKAGE, AND THE REFINED MODELS WERE ADJUSTED TO REMARK 3 REFLECT THE INITIAL, RADIATION-DAMAGE FREE STRUCTURE. HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 4 REMARK 4 2NY0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-JAN-07. REMARK 100 THE DEPOSITION ID IS D_1000040442. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-OCT-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0723 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 225 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54639 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.9 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.11900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 59.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1GC1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7.5% PEG 8000, 7.5% MPD, 100 MM NA REMARK 280 CITRATE, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 98.22950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 98.22950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TRP A 400 REMARK 465 SER A 401 REMARK 465 THR A 402 REMARK 465 GLU A 403 REMARK 465 GLY A 404 REMARK 465 SER A 405 REMARK 465 ASN A 406 REMARK 465 ASN A 407 REMARK 465 THR A 408 REMARK 465 GLU A 409 REMARK 465 GLU A 492 REMARK 465 MET B 1000 REMARK 465 ALA B 1182 REMARK 465 SER B 1183 REMARK 465 SER D 3142 REMARK 465 SER D 3143 REMARK 465 LYS D 3144 REMARK 465 SER D 3145 REMARK 465 THR D 3146 REMARK 465 SER D 3147 REMARK 465 GLY D 3148 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU A 111 O HOH A 5040 1.84 REMARK 500 N GLU A 83 O HOH A 5065 1.94 REMARK 500 OE1 GLU A 211 O HOH A 5030 2.00 REMARK 500 SG CYS C 2196 O HOH C 139 2.07 REMARK 500 O ASP B 1078 O HOH B 237 2.12 REMARK 500 O SER D 3135 O HOH D 342 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 5120 O HOH A 5120 4556 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 88 -10.69 69.38 REMARK 500 LEU A 125 85.54 -160.23 REMARK 500 GLN A 258 -53.38 68.27 REMARK 500 GLU A 268 -95.74 -114.24 REMARK 500 ASN A 276 92.97 -174.30 REMARK 500 ASN A 392 62.46 -159.74 REMARK 500 ASN A 397 -90.51 -93.82 REMARK 500 SER A 398 -85.53 -84.69 REMARK 500 LYS A 429 176.71 178.60 REMARK 500 ASN A 460 108.19 -52.63 REMARK 500 ASN A 462 1.60 -67.79 REMARK 500 LEU B1037 139.38 -177.23 REMARK 500 PRO B1048 42.46 -87.09 REMARK 500 SER B1057 -162.73 -122.74 REMARK 500 GLU B1087 50.57 35.79 REMARK 500 GLN B1165 -38.77 79.13 REMARK 500 SER C2030 -114.89 52.16 REMARK 500 ALA C2051 -34.07 76.18 REMARK 500 ALA C2084 -172.74 -172.09 REMARK 500 LYS C2192 -74.18 -96.30 REMARK 500 ARG C2213 104.19 -50.91 REMARK 500 LEU D3139 75.47 -107.60 REMARK 500 ASP D3159 55.88 71.13 REMARK 500 PRO D3228 -159.30 -60.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1GC1 RELATED DB: PDB REMARK 900 THE SAME TERNARY COMPLEX AT 2.5 A REMARK 900 RELATED ID: 1RZJ RELATED DB: PDB REMARK 900 THE SAME TERNARY COMPLEX AT 2.2 A REMARK 900 RELATED ID: 1RZK RELATED DB: PDB REMARK 900 THE SAME TERNARY COMPLEX FROM A PRIMARY ISOLATE REMARK 900 RELATED ID: 2NXY RELATED DB: PDB REMARK 900 RELATED ID: 2NXZ RELATED DB: PDB REMARK 900 RELATED ID: 2NY1 RELATED DB: PDB REMARK 900 RELATED ID: 2NY2 RELATED DB: PDB REMARK 900 RELATED ID: 2NY3 RELATED DB: PDB REMARK 900 RELATED ID: 2NY4 RELATED DB: PDB REMARK 900 RELATED ID: 2NY5 RELATED DB: PDB REMARK 900 RELATED ID: 2NY6 RELATED DB: PDB REMARK 900 RELATED ID: 2NY7 RELATED DB: PDB DBREF 2NY0 B 1001 1183 UNP P01730 CD4_HUMAN 26 208 DBREF 2NY0 A 88 492 UNP Q8QDX5 Q8QDX5_9HIV1 157 468 DBREF 2NY0 C 2002 2214 UNP Q6P5S8 Q6P5S8_HUMAN 22 234 DBREF 2NY0 D 3001 3229 UNP Q6PJA4 Q6PJA4_HUMAN 20 241 SEQADV 2NY0 MET B 1000 UNP P01730 INITIATING METHIONINE SEQRES 1 A 317 GLU VAL VAL LEU VAL ASN VAL THR GLU ASN PHE ASN TRP SEQRES 2 A 317 CYS LYS ASN ASP MET VAL GLU GLN MET HIS GLU ASP ILE SEQRES 3 A 317 ILE SER LEU TRP ASP GLN SER LEU LYS PRO CYS VAL LYS SEQRES 4 A 317 LEU THR PRO LEU CYS VAL GLY ALA GLY SER CYS ASN THR SEQRES 5 A 317 SER VAL ILE THR GLN ALA CYS PRO LYS VAL SER PHE GLU SEQRES 6 A 317 PRO ILE PRO ILE HIS TYR CYS ALA PRO ALA GLY PHE ALA SEQRES 7 A 317 ILE LEU LYS CYS ASN ASN LYS THR PHE ASN GLY THR GLY SEQRES 8 A 317 PRO CYS THR ASN VAL SER THR VAL GLN CYS THR HIS GLY SEQRES 9 A 317 ILE ARG PRO VAL VAL SER SER GLN LEU LEU LEU ASN GLY SEQRES 10 A 317 SER LEU ALA GLU GLU GLU VAL VAL ILE ARG SER CYS ASN SEQRES 11 A 317 PHE THR ASP ASN ALA LYS THR ILE ILE VAL GLN LEU ASN SEQRES 12 A 317 THR SER VAL GLU ILE ASN CYS THR GLY ALA GLY HIS CYS SEQRES 13 A 317 ASN ILE ALA ARG ALA LYS TRP ASN ASN THR LEU LYS GLN SEQRES 14 A 317 ILE ALA SER LYS LEU ARG GLU GLN PHE GLY ASN ASN LYS SEQRES 15 A 317 THR ILE ILE PHE LYS GLN SER SER GLY GLY ASP PRO GLU SEQRES 16 A 317 ILE VAL THR HIS TRP PHE ASN CYS GLY GLY GLU PHE PHE SEQRES 17 A 317 TYR CYS ASN SER THR GLN LEU PHE ASN SER THR TRP PHE SEQRES 18 A 317 ASN SER THR TRP SER THR GLU GLY SER ASN ASN THR GLU SEQRES 19 A 317 GLY SER ASP THR ILE THR LEU PRO CYS ARG ILE LYS GLN SEQRES 20 A 317 ILE ILE ASN MET TRP GLN LYS VAL GLY LYS MET MET TYR SEQRES 21 A 317 ALA PRO PRO ILE SER GLY GLN ILE ARG CYS SER SER ASN SEQRES 22 A 317 ILE THR GLY LEU LEU LEU THR ARG ASP GLY GLY ASN SER SEQRES 23 A 317 ASN ASN GLU SER GLU ILE PHE ARG PRO GLY GLY GLY ASP SEQRES 24 A 317 MET ARG ASP ASN TRP ARG SER GLU LEU TYR LYS TYR LYS SEQRES 25 A 317 VAL VAL LYS ILE GLU SEQRES 1 B 184 MET LYS LYS VAL VAL LEU GLY LYS LYS GLY ASP THR VAL SEQRES 2 B 184 GLU LEU THR CYS THR ALA SER GLN LYS LYS SER ILE GLN SEQRES 3 B 184 PHE HIS TRP LYS ASN SER ASN GLN ILE LYS ILE LEU GLY SEQRES 4 B 184 ASN GLN GLY SER PHE LEU THR LYS GLY PRO SER LYS LEU SEQRES 5 B 184 ASN ASP ARG ALA ASP SER ARG ARG SER LEU TRP ASP GLN SEQRES 6 B 184 GLY ASN PHE PRO LEU ILE ILE LYS ASN LEU LYS ILE GLU SEQRES 7 B 184 ASP SER ASP THR TYR ILE CYS GLU VAL GLU ASP GLN LYS SEQRES 8 B 184 GLU GLU VAL GLN LEU LEU VAL PHE GLY LEU THR ALA ASN SEQRES 9 B 184 SER ASP THR HIS LEU LEU GLN GLY GLN SER LEU THR LEU SEQRES 10 B 184 THR LEU GLU SER PRO PRO GLY SER SER PRO SER VAL GLN SEQRES 11 B 184 CYS ARG SER PRO ARG GLY LYS ASN ILE GLN GLY GLY LYS SEQRES 12 B 184 THR LEU SER VAL SER GLN LEU GLU LEU GLN ASP SER GLY SEQRES 13 B 184 THR TRP THR CYS THR VAL LEU GLN ASN GLN LYS LYS VAL SEQRES 14 B 184 GLU PHE LYS ILE ASP ILE VAL VAL LEU ALA PHE GLN LYS SEQRES 15 B 184 ALA SER SEQRES 1 C 214 ASP ILE VAL MET THR GLN SER PRO ALA THR LEU SER VAL SEQRES 2 C 214 SER PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 C 214 GLU SER VAL SER SER ASP LEU ALA TRP TYR GLN GLN LYS SEQRES 4 C 214 PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR GLY ALA SER SEQRES 5 C 214 THR ARG ALA THR GLY VAL PRO ALA ARG PHE SER GLY SER SEQRES 6 C 214 GLY SER GLY ALA GLU PHE THR LEU THR ILE SER SER LEU SEQRES 7 C 214 GLN SER GLU ASP PHE ALA VAL TYR TYR CYS GLN GLN TYR SEQRES 8 C 214 ASN ASN TRP PRO PRO ARG TYR THR PHE GLY GLN GLY THR SEQRES 9 C 214 ARG LEU GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL SEQRES 10 C 214 PHE ILE PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY SEQRES 11 C 214 THR ALA SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO SEQRES 12 C 214 ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU SEQRES 13 C 214 GLN SER GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SEQRES 14 C 214 SER LYS ASP SER THR TYR SER LEU SER SER THR LEU THR SEQRES 15 C 214 LEU SER LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA SEQRES 16 C 214 CYS GLU VAL THR HIS GLN GLY LEU SER SER PRO VAL THR SEQRES 17 C 214 LYS SER PHE ASN ARG GLY SEQRES 1 D 229 GLU VAL GLN LEU VAL GLU SER GLY ALA GLU VAL LYS LYS SEQRES 2 D 229 PRO GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY SEQRES 3 D 229 ASP THR PHE ILE ARG TYR SER PHE THR TRP VAL ARG GLN SEQRES 4 D 229 ALA PRO GLY GLN GLY LEU GLU TRP MET GLY ARG ILE ILE SEQRES 5 D 229 THR ILE LEU ASP VAL ALA HIS TYR ALA PRO HIS LEU GLN SEQRES 6 D 229 GLY ARG VAL THR ILE THR ALA ASP LYS SER THR SER THR SEQRES 7 D 229 VAL TYR LEU GLU LEU ARG ASN LEU ARG SER ASP ASP THR SEQRES 8 D 229 ALA VAL TYR PHE CYS ALA GLY VAL TYR GLU GLY GLU ALA SEQRES 9 D 229 ASP GLU GLY GLU TYR ASP ASN ASN GLY PHE LEU LYS HIS SEQRES 10 D 229 TRP GLY GLN GLY THR LEU VAL THR VAL SER SER ALA SER SEQRES 11 D 229 THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SER SER SEQRES 12 D 229 LYS SER THR SER GLY GLY THR ALA ALA LEU GLY CYS LEU SEQRES 13 D 229 VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SER TRP SEQRES 14 D 229 ASN SER GLY ALA LEU THR SER GLY VAL HIS THR PHE PRO SEQRES 15 D 229 ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SER SER SEQRES 16 D 229 VAL VAL THR VAL PRO SER SER SER LEU GLY THR GLN THR SEQRES 17 D 229 TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN THR LYS SEQRES 18 D 229 VAL ASP LYS LYS VAL GLU PRO LYS MODRES 2NY0 ASN A 88 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 234 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 241 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 262 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 276 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 289 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 295 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 339 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 386 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 392 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 448 ASN GLYCOSYLATION SITE MODRES 2NY0 ASN A 463 ASN GLYCOSYLATION SITE HET NAG A 588 14 HET NAG A 734 14 HET NAG A 741 14 HET NAG A 762 14 HET NAG A 776 14 HET NAG A 789 14 HET NAG A 795 14 HET NAG A 839 14 HET NAG A 886 14 HET NAG A 892 14 HET NAG A 948 14 HET NAG A 963 14 HET HEZ A5000 8 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM HEZ HEXANE-1,6-DIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 5 NAG 12(C8 H15 N O6) FORMUL 17 HEZ C6 H14 O2 FORMUL 18 HOH *381(H2 O) HELIX 1 1 ASN A 98 GLN A 114 1 17 HELIX 2 2 ARG A 335 GLY A 354 1 20 HELIX 3 3 ASP A 368 THR A 373 1 6 HELIX 4 4 SER A 387 PHE A 391 5 5 HELIX 5 5 ASP A 474 TYR A 484 1 11 HELIX 6 6 LEU B 1051 ASP B 1053 5 3 HELIX 7 7 ARG B 1058 GLY B 1065 5 8 HELIX 8 8 LYS B 1075 SER B 1079 5 5 HELIX 9 9 GLU B 1150 SER B 1154 5 5 HELIX 10 10 GLN C 2079 PHE C 2083 5 5 HELIX 11 11 SER C 2123 GLY C 2130 1 8 HELIX 12 12 LYS C 2185 GLU C 2189 1 5 HELIX 13 13 THR D 3028 ILE D 3030 5 3 HELIX 14 14 ARG D 3087 THR D 3091 5 5 HELIX 15 15 GLU D 3103 GLY D 3107 5 5 HELIX 16 16 SER D 3171 ALA D 3173 5 3 HELIX 17 17 LYS D 3216 ASN D 3219 5 4 SHEET 1 A 4 VAL A 84 LEU A 86 0 SHEET 2 A 4 VAL A 242 VAL A 245 -1 O VAL A 242 N LEU A 86 SHEET 3 A 4 PHE A 223 CYS A 228 -1 N LYS A 227 O SER A 243 SHEET 4 A 4 TYR A 486 LYS A 490 -1 O LYS A 487 N LEU A 226 SHEET 1 B 2 GLU A 91 ASN A 94 0 SHEET 2 B 2 THR A 236 CYS A 239 -1 O CYS A 239 N GLU A 91 SHEET 1 C 4 ASN A 197 THR A 202 0 SHEET 2 C 4 VAL A 120 LEU A 125 -1 N THR A 123 O SER A 199 SHEET 3 C 4 LYS A 432 MET A 434 -1 O LYS A 432 N LEU A 122 SHEET 4 C 4 ILE A 423 ASN A 425 -1 N ILE A 424 O MET A 433 SHEET 1 D 7 LEU A 259 LEU A 261 0 SHEET 2 D 7 ARG A 444 ARG A 456 -1 O THR A 450 N LEU A 260 SHEET 3 D 7 ILE A 284 THR A 297 -1 N ILE A 284 O LEU A 454 SHEET 4 D 7 HIS A 330 ALA A 334 -1 O ASN A 332 N ASN A 295 SHEET 5 D 7 THR A 413 LYS A 421 -1 O ILE A 414 N ILE A 333 SHEET 6 D 7 GLU A 381 CYS A 385 -1 N TYR A 384 O ARG A 419 SHEET 7 D 7 HIS A 374 CYS A 378 -1 N CYS A 378 O GLU A 381 SHEET 1 E 6 VAL A 271 ARG A 273 0 SHEET 2 E 6 ILE A 284 THR A 297 -1 O GLN A 287 N VAL A 271 SHEET 3 E 6 ARG A 444 ARG A 456 -1 O LEU A 454 N ILE A 284 SHEET 4 E 6 SER A 465 PRO A 470 -1 O ARG A 469 N THR A 455 SHEET 5 E 6 THR A 358 PHE A 361 1 N ILE A 360 O GLU A 466 SHEET 6 E 6 SER A 393 TRP A 395 -1 O SER A 393 N PHE A 361 SHEET 1 F 6 LYS B1002 LYS B1007 0 SHEET 2 F 6 GLN B1089 ALA B1102 1 O LEU B1096 N GLY B1006 SHEET 3 F 6 ASP B1080 VAL B1086 -1 N ASP B1080 O LEU B1095 SHEET 4 F 6 PHE B1026 ASN B1030 -1 N LYS B1029 O ILE B1083 SHEET 5 F 6 LYS B1035 GLN B1040 -1 O LEU B1037 N TRP B1028 SHEET 6 F 6 PHE B1043 LYS B1046 -1 O PHE B1043 N GLN B1040 SHEET 1 G 4 LYS B1002 LYS B1007 0 SHEET 2 G 4 GLN B1089 ALA B1102 1 O LEU B1096 N GLY B1006 SHEET 3 G 4 LEU B1114 GLU B1119 -1 O GLU B1119 N GLY B1099 SHEET 4 G 4 THR B1143 VAL B1146 -1 O LEU B1144 N LEU B1116 SHEET 1 H 3 VAL B1012 LEU B1014 0 SHEET 2 H 3 LEU B1069 ILE B1071 -1 O LEU B1069 N LEU B1014 SHEET 3 H 3 ALA B1055 ASP B1056 -1 N ASP B1056 O ILE B1070 SHEET 1 I 2 LEU B1108 LEU B1109 0 SHEET 2 I 2 VAL B1176 LEU B1177 1 O LEU B1177 N LEU B1108 SHEET 1 J 4 ASN B1137 GLY B1140 0 SHEET 2 J 4 SER B1127 ARG B1131 -1 N CYS B1130 O ILE B1138 SHEET 3 J 4 GLY B1155 GLN B1163 -1 O THR B1160 N GLN B1129 SHEET 4 J 4 LYS B1166 ILE B1174 -1 O PHE B1170 N CYS B1159 SHEET 1 K 4 MET C2004 SER C2007 0 SHEET 2 K 4 ALA C2019 ALA C2025 -1 O ARG C2024 N THR C2005 SHEET 3 K 4 GLU C2070 ILE C2075 -1 O LEU C2073 N LEU C2021 SHEET 4 K 4 PHE C2062 SER C2067 -1 N SER C2063 O THR C2074 SHEET 1 L 6 THR C2010 VAL C2013 0 SHEET 2 L 6 THR C2104 ILE C2108 1 O ARG C2105 N LEU C2011 SHEET 3 L 6 ALA C2084 GLN C2090 -1 N ALA C2084 O LEU C2106 SHEET 4 L 6 LEU C2033 GLN C2038 -1 N TYR C2036 O TYR C2087 SHEET 5 L 6 ARG C2045 TYR C2049 -1 O LEU C2047 N TRP C2035 SHEET 6 L 6 THR C2053 ARG C2054 -1 O THR C2053 N TYR C2049 SHEET 1 M 4 THR C2010 VAL C2013 0 SHEET 2 M 4 THR C2104 ILE C2108 1 O ARG C2105 N LEU C2011 SHEET 3 M 4 ALA C2084 GLN C2090 -1 N ALA C2084 O LEU C2106 SHEET 4 M 4 THR C2099 PHE C2100 -1 O THR C2099 N GLN C2090 SHEET 1 N 4 SER C2116 PHE C2120 0 SHEET 2 N 4 THR C2131 PHE C2141 -1 O LEU C2137 N PHE C2118 SHEET 3 N 4 TYR C2175 SER C2184 -1 O SER C2179 N CYS C2136 SHEET 4 N 4 SER C2161 VAL C2165 -1 N SER C2164 O SER C2178 SHEET 1 O 3 LYS C2147 VAL C2152 0 SHEET 2 O 3 VAL C2193 THR C2199 -1 O GLU C2197 N GLN C2149 SHEET 3 O 3 VAL C2207 ASN C2212 -1 O VAL C2207 N VAL C2198 SHEET 1 P 4 GLN D3003 GLU D3006 0 SHEET 2 P 4 VAL D3018 SER D3025 -1 O SER D3025 N GLN D3003 SHEET 3 P 4 THR D3078 LEU D3083 -1 O LEU D3081 N VAL D3020 SHEET 4 P 4 VAL D3068 ASP D3073 -1 N THR D3071 O TYR D3080 SHEET 1 Q 6 GLU D3010 LYS D3012 0 SHEET 2 Q 6 THR D3122 VAL D3126 1 O THR D3125 N LYS D3012 SHEET 3 Q 6 ALA D3092 TYR D3100 -1 N TYR D3094 O THR D3122 SHEET 4 Q 6 TYR D3032 GLN D3039 -1 N VAL D3037 O PHE D3095 SHEET 5 Q 6 LEU D3045 ILE D3052 -1 O ILE D3051 N PHE D3034 SHEET 6 Q 6 VAL D3057 TYR D3060 -1 O VAL D3057 N ILE D3052 SHEET 1 R 4 GLU D3010 LYS D3012 0 SHEET 2 R 4 THR D3122 VAL D3126 1 O THR D3125 N LYS D3012 SHEET 3 R 4 ALA D3092 TYR D3100 -1 N TYR D3094 O THR D3122 SHEET 4 R 4 HIS D3117 TRP D3118 -1 O HIS D3117 N GLY D3098 SHEET 1 S 4 SER D3135 LEU D3139 0 SHEET 2 S 4 THR D3150 TYR D3160 -1 O GLY D3154 N LEU D3139 SHEET 3 S 4 TYR D3191 PRO D3200 -1 O LEU D3193 N VAL D3157 SHEET 4 S 4 VAL D3178 THR D3180 -1 N HIS D3179 O VAL D3196 SHEET 1 T 4 SER D3135 LEU D3139 0 SHEET 2 T 4 THR D3150 TYR D3160 -1 O GLY D3154 N LEU D3139 SHEET 3 T 4 TYR D3191 PRO D3200 -1 O LEU D3193 N VAL D3157 SHEET 4 T 4 VAL D3184 LEU D3185 -1 N VAL D3184 O SER D3192 SHEET 1 U 3 THR D3166 TRP D3169 0 SHEET 2 U 3 TYR D3209 HIS D3215 -1 O ASN D3212 N SER D3168 SHEET 3 U 3 THR D3220 VAL D3226 -1 O VAL D3222 N VAL D3213 SSBOND 1 CYS A 96 CYS A 275 1555 1555 2.03 SSBOND 2 CYS A 119 CYS A 205 1555 1555 2.04 SSBOND 3 CYS A 126 CYS A 196 1555 1555 2.04 SSBOND 4 CYS A 218 CYS A 247 1555 1555 2.04 SSBOND 5 CYS A 228 CYS A 239 1555 1555 2.04 SSBOND 6 CYS A 296 CYS A 331 1555 1555 2.04 SSBOND 7 CYS A 378 CYS A 445 1555 1555 2.04 SSBOND 8 CYS A 385 CYS A 418 1555 1555 2.04 SSBOND 9 CYS B 1016 CYS B 1084 1555 1555 2.04 SSBOND 10 CYS B 1130 CYS B 1159 1555 1555 2.03 SSBOND 11 CYS C 2023 CYS C 2088 1555 1555 2.07 SSBOND 12 CYS C 2136 CYS C 2196 1555 1555 2.04 SSBOND 13 CYS D 3022 CYS D 3096 1555 1555 2.05 SSBOND 14 CYS D 3155 CYS D 3211 1555 1555 2.04 LINK ND2 ASN A 88 C1 NAG A 588 1555 1555 1.44 LINK ND2 ASN A 234 C1 NAG A 734 1555 1555 1.44 LINK ND2 ASN A 241 C1 NAG A 741 1555 1555 1.44 LINK ND2 ASN A 262 C1 NAG A 762 1555 1555 1.44 LINK ND2 ASN A 276 C1 NAG A 776 1555 1555 1.45 LINK ND2 ASN A 289 C1 NAG A 789 1555 1555 1.44 LINK ND2 ASN A 295 C1 NAG A 795 1555 1555 1.44 LINK ND2 ASN A 339 C1 NAG A 839 1555 1555 1.44 LINK ND2 ASN A 386 C1 NAG A 886 1555 1555 1.44 LINK ND2 ASN A 392 C1 NAG A 892 1555 1555 1.44 LINK ND2 ASN A 448 C1 NAG A 948 1555 1555 1.45 LINK ND2 ASN A 463 C1 NAG A 963 1555 1555 1.45 CISPEP 1 SER C 2007 PRO C 2008 0 -4.10 CISPEP 2 TRP C 2094 PRO C 2095 0 -0.58 CISPEP 3 TYR C 2142 PRO C 2143 0 -3.37 CISPEP 4 PHE D 3161 PRO D 3162 0 -9.74 CISPEP 5 GLU D 3163 PRO D 3164 0 -4.12 CRYST1 71.887 87.309 196.459 90.00 90.00 90.00 P 2 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013911 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011454 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005090 0.00000